Their findings unveiled characteristic RyR mutational patterns in cancers and established correlations with tumor mutational burden (TMB), patient prognosis, age, and smoking status; however, rhabdomyosarcomas were not evaluated. The gene discussed is RYR2; the disease is rhabdomyosarcoma.